Controlled Myelofibrosis Study with Oral JAK Inhibitor Treatment

Tell Your Colleagues

If you have a colleague who would be interested in finding out more about the COMFORT trials, fill out the information below and we will send an e-mail containing a link to www.comfortstudy.com. An (*) indicates a required field.

*Your name:
*Your e-mail address:
*Your colleague’s name:
*Your colleague’s e-mail address:
Your message (optional):

..........................................................................................................................................................................................................................................................................................................................

This is an international Web site for the COMFORT-I and COMFORT-II trials. The information on this site is not country-specific and may contain trial information that is different from where you practice. INCB018424 is investigational. Efficacy and safety have not been established. There is no guarantee that this compound will become commercially available.